Plasma Supply Subject of Conference in Baltimore.
ANNAPOLIS, Md., June 4 /PRNewswire/ -- The Plasma Protein Therapeutics Association (PPTA) and ABRA, the international association for the source plasma collection industry, are hosting a conference of representatives from the plasma collection and plasma fractionation industry, June 6 - 8 at the Marriott Waterfront Hotel, Baltimore....

New England Journal of Medicine Study Demonstrates Feasibility Of Using Umbilical Cord Blood in Adult Transplants.
Recent Study Expands Body of Science Supporting Use of Cord Blood Stem Cells BOSTON, June 20 /PRNewswire/ -- A recent article published by Laughlin, et. al. on June 14, 2001, in the New England Journal of Medicine (NEJM) further validates new options available to patients...

Hollis-Eden Continues Expansion of R&D Group.
SAN DIEGO, Feb. 1 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) today announced several new appointments in the areas of clinical research, drug discovery and intellectual property, consistent with the Company's anticipated expansion of pre-clinical and clinical trial activity. Included in the appointments were Elizabeth E Morgan,...

CEOs From Sonus, SciClone and Cellegy Join Two Other Pharma Firms and Analyst David Saks on Webcast Stocks Forum Today.
ROSEVILLE, Calif., Feb. 13 /PRNewswire/ -- Many small pharmaceuticals quietly work with little fanfare on numerous products holding significant promise. For insight into five such companies plus an introduction and overview of the sector from noted biopharma analyst David Saks of Gruntal & Co., tune into today's...

Hematech Receives Milestone Payment from its Polyclonal Antibody Collaboration with Kirin.
WESTPORT, Conn., March 5 /PRNewswire/ -- Hematech LLC, a privately-held company pioneering the development and production of polyclonal and monoclonal antibodies, today announced that the Company has received a milestone payment from its collaboration with the pharmaceutical division of Kirin Brewery Company, Ltd. The collaboration, initiated in...

Acupuncture can curb musculoskeletal pain. (Training, Liability, Issues).
SAN DIEGO -- Acupuncture may be ready to play a greater role in treating musculoskeletal pain in primary care practice, Dr. Robert Bonakdar said at the annual meeting of the American Academy of Family Physicians. Evidence that acupuncture produces a physiologic response can be found in studies...

ExonHit Launches Mouse Genome SpliceArray(TM) for use in Human Disease Modeling Studies.
PARIS, November 28 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext: ALEHT), a drug and diagnostic discovery company, announces today the availability of its new SpliceArray(TM) for use in studying mouse models of human disease. These SpliceArray(TM) products help our clients accelerate and refine their therapeutic target discovery and validation efforts....

Science in the Courtroom A New Approach.
Judges, legislators, policymakers and often base decisions concerning health risks on evidence and testimony from scientists, physicians, and other experts. Unfortunately, the quality of this information can be questionable and its implications unclear. How are nonscientists to determine which expert presentations provide the strongest basis for law and policy?...

Chasing cancer; Vaccine may target deadly threats.
Byline: Lisa Eckelbecker WORCESTER - A technology developed by Antigen Express Inc. to bolster therapeutic vaccines has shown early signs of progress in breast cancer and is also being tested in early studies of avian flu and prostate cancer. The technology, which depends on peptides...

BioVex Forms Target Validation Business and Signs Agreement With Leading US Biopharmaceutical Company.
BioVex Is a Leading Gene Delivery Company SAN FRANCISCO, Jan. 9 /PRNewswire/ -- JP Morgan H&Q, 19th Annual Healthcare Conference: BioVex Limited, one of the UK's leading gene delivery companies, announced today that it has established a dedicated business in the field of target validation...